Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: Mike M who wrote (1083)	10/19/1999 5:42:00 PM
From: DanZ	Read Replies (1) \| Respond to of 5582

I liken the price of Zicam to milk. The absolute price of a quart is cheaper than a gallon, but the price per ounce is higher. I posted a comparison of the cost per dose of Zicam to several popular name-brand cold remedies a few months ago on Yahoo. Zicam had a lower cost per dose than Tylenol Cold, Sudafed, Contac, and Theraflu, to name a few. I guess they could sell a smaller bottle for less if the perception persists that Zicam is expensive, but I don't think the price will be an issue if the clinical studies come back favorable. They might even be able to raise the price if the demand is high enough. I don't know if the subjects were asked to report side effects (such as stinging) during the clinical studies. GumTech conducted a focus group a few months ago, and they probably looked into this issue then.